Novel Plasmalogen Derivatives
    1.
    发明申请

    公开(公告)号:US20210238208A1

    公开(公告)日:2021-08-05

    申请号:US17050905

    申请日:2019-04-18

    IPC分类号: C07F9/10 A61P25/28

    摘要: A compound presented by the following Chemical Formula 1, a racemic form, or a salt thereof: wherein, X represents an oxygen atom, a nitrogen atom, a sulfur atom, or a carbon atom, R1 represents R1a—Y—R1b (wherein R1a and R1b each independently represent a saturated or unsaturated aliphatic hydrocarbon group, an aromatic group, a heterocyclic group, or a combination thereof, and Y represents an oxygen atom, a nitrogen atom, a sulfur atom, or a carbon atom), R2 represents a saturated or unsaturated aliphatic hydrocarbon group, and R3 represents choline, ethanolamine, inositol, or serine.

    Ether phospholipids and method for producing the same

    公开(公告)号:US11066432B2

    公开(公告)日:2021-07-20

    申请号:US15533528

    申请日:2015-05-13

    摘要: [PROBLEM TO BE SOLVED] It enables any superior ether phospholipids to the conventional ones and a method for producing the same in an easy manner on a massive scale, in light of effects of treating and improving brain diseases such as Alzheimer's disease, Parkinson disease, depression and schizophrenia, metabolic diseases such as diabetes, various infectious diseases, and immune disorders. [SOLUTION] Ether phospholipids are obtained from bivalve tissues such as clams and corbicula by extraction processing. The ether phospholipids exhibit significantly superior effects of the above as compared to the conventional ether phospholipids derived from chicken tissues.

    Uses of ether phospholipids in treating diseases

    公开(公告)号:US10653708B2

    公开(公告)日:2020-05-19

    申请号:US15625151

    申请日:2017-06-16

    摘要: The present invention relates to uses of ether phospholipids in treating and preventing various diseases, including, but not limited to, neurodegenerative or brain diseases such as Alzheimer's disease, cognitive impairment, brain fatigue, Parkinson disease, depression, anxiety disorder, insomnia and schizophrenia; metabolic syndrome such as diabetes and obesity; various infectious diseases such as viral diseases; diseases related to inflammation; heart diseases, and immune disorders. Preferably, the ether phospholipids are derived from extracting bivalves, which provides superior efficacies in treating and preventing the diseases.

    Method for quantifying plasmalogens using PLA1 processing

    公开(公告)号:US10324100B2

    公开(公告)日:2019-06-18

    申请号:US15478487

    申请日:2017-04-04

    摘要: The present invention provides methods for quantifying an amount of plasmalogens in samples with high accuracy in an easy, convenient and inexpensive manner by using a hydrolysis processing to samples and a lipid extraction followed by the measurement using High Performance Liquid Chromatography (HPLC) with Evaporative Light Scattering Detector (ELSD) or Mass Spectrometer (MS), a fluorescence plate reader or a plate reader. The present invention also relates to a method for examining a subject by using the above method, a biomarker for disease detection, a method for using the biomarker for the disease detection, as well as a kit for the disease detection.